MOMTAZEE JAMES C
Insider CIK 1209181 · JAZZ Director · ENTL Director · PRAH Director · ROIV Director · BBIO Director, 10% owner · MAAC Chief Executive Officer, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2026-10-23 | 2026-10-27 | 77 | $36.49 | $2.8K | 112,265 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2026-10-23 | 2026-10-27 | 383 | — | $0 | 112,342 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award deriv | 2026-09-16 | 2026-09-18 | 10,531 | — | $0 | 10,531 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2026-09-16 | 2026-09-18 | 5,054 | — | $0 | 111,959 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award deriv | 2026-09-16 | 2026-09-18 | 10,531 | — | $0 | 10,531 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2026-09-16 | 2026-09-18 | 5,054 | — | $0 | 111,959 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2026-09-10 | 2026-09-14 | 2,905 | $40.94 | $118.9K | 106,905 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2026-09-10 | 2026-09-14 | 2,905 | $40.94 | $118.9K | 106,905 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2026-07-17 | 2026-07-21 | 405 | — | $0 | 109,810 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2026-06-22 | 2026-06-24 | 5,277 | — | $0 | 5,277 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award | 2026-06-22 | 2026-06-24 | 3,990 | — | $0 | 19,070 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2026-04-17 | 2026-04-21 | 469 | — | $0 | 109,499 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2026-04-17 | 2026-04-21 | 94 | $29.83 | $2.8K | 109,405 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2026-01-20 | 2026-01-22 | 609 | — | $0 | 109,152 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2026-01-20 | 2026-01-22 | 122 | $22.98 | $2.8K | 109,030 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2025-10-20 | 2025-10-22 | 158 | $17.74 | $2.8K | 108,543 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2025-10-20 | 2025-10-22 | 789 | — | $0 | 108,701 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award deriv | 2025-09-10 | 2025-09-12 | 33,726 | — | $0 | 33,726 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2025-09-10 | 2025-09-12 | 14,524 | — | $0 | 111,194 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2025-09-10 | 2025-09-12 | 3,282 | $13.77 | $45.2K | 107,912 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2025-07-17 | 2025-07-21 | 241 | $11.65 | $2.8K | 96,670 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2025-07-17 | 2025-07-21 | 1,201 | — | $0 | 96,911 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2025-06-20 | 2025-06-24 | 8,425 | — | $0 | 8,425 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award | 2025-06-20 | 2025-06-24 | 6,589 | — | $0 | 95,080 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2025-04-17 | 2025-04-21 | 276 | $10.15 | $2.8K | 95,710 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2025-04-17 | 2025-04-21 | 1,379 | — | $0 | 95,986 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2025-01-23 | 2025-01-27 | 306 | $11.21 | $3.4K | 94,607 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2025-01-23 | 2025-01-27 | 1,248 | — | $0 | 94,913 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2024-10-21 | 2024-10-23 | 1,231 | — | $0 | 93,665 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2024-09-12 | 2024-09-16 | 3,056 | $12.12 | $37.0K | 92,434 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award deriv | 2024-09-10 | 2024-09-12 | 27,894 | — | $0 | 27,894 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2024-09-10 | 2024-09-12 | 16,406 | — | $0 | 95,490 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2024-07-23 | 2024-07-25 | 1,555 | — | $0 | 79,091 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2024-06-21 | 2024-06-25 | 26,014 | — | $0 | 26,014 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2024-04-24 | 2024-04-26 | 293 | $10.90 | $3.2K | 77,536 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2024-04-24 | 2024-04-26 | 1,490 | — | $0 | 77,829 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2024-01-19 | 2024-01-23 | 1,570 | — | $0 | 76,339 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2023-10-17 | 2023-10-18 | 687 | $10.30 | $7.1K | 74,769 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2023-09-18 | 2023-09-20 | 6,752 | $11.17 | $75.4K | 73,862 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award deriv | 2023-09-12 | 2023-09-14 | 26,595 | — | $0 | 26,595 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2023-09-12 | 2023-09-14 | 17,825 | — | $0 | 80,614 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2023-07-03 | 2023-07-06 | 1,664 | — | $0 | 62,789 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2023-06-21 | 2023-06-23 | 51,501 | — | $0 | 51,501 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2023-04-03 | 2023-04-05 | 1,351 | — | $0 | 61,125 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2023-01-03 | 2023-01-05 | 2,447 | — | $0 | 59,774 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2022-10-31 | 2022-11-02 | 3,404 | — | $0 | 57,327 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2022-10-16 | 2023-10-18 | 1,594 | — | $0 | 75,456 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award deriv | 2022-09-15 | 2022-09-19 | 68,897 | — | $0 | 68,897 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2022-09-15 | 2022-09-19 | 50,000 | — | $0 | 53,923 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2022-07-20 | 2022-07-25 | 3,923 | — | $0 | 3,923 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 104,921 | — | $0 | 104,921 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | P Buy | 2021-12-29 | 2022-01-03 | 80,000 | $14.50 | $1.16M | 88,491 | SEC↗ |
| PRAH PRA Health Sciences, Inc. | D To issuer | 2021-07-01 | 2021-07-01 | 3,521 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2021-06-17 | 2021-06-22 | 38,895 | — | $0 | 38,895 | SEC↗ |
| PRAH PRA Health Sciences, Inc. | A Award | 2021-06-01 | 2021-06-03 | 330 | — | $0 | 3,521 | SEC↗ |
| MAAC Montes Archimedes Acquisit | J Other deriv | 2020-11-20 | 2020-11-20 | 1,232,044 | — | $0 | 10,167,956 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-06-02 | 2020-06-04 | 112,422 | — | $0 | 112,422 | SEC↗ |
| PRAH PRA Health Sciences, Inc. | A Award | 2020-05-18 | 2020-05-20 | 1,748 | — | $0 | 3,191 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-02-12 | 2020-02-14 | 24,927 | — | $0 | 24,927 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award | 2020-02-12 | 2020-02-14 | 8,491 | — | $0 | 8,491 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2019-12-12 | 2019-12-16 | 82,878 | — | $0 | 82,878 | SEC↗ |
| PRAH PRA Health Sciences, Inc. | A Award | 2019-08-13 | 2019-08-15 | 1,443 | — | $0 | 1,443 | SEC↗ |
| ENTL ENTELLUS MEDICAL INC | D To issuer deriv | 2018-02-28 | 2018-03-01 | 7,500 | $6.33 | $47.5K | 0 | SEC↗ |
| ENTL ENTELLUS MEDICAL INC | D To issuer | 2018-02-28 | 2018-03-01 | 3,750 | $24.00 | $90.0K | 0 | SEC↗ |
| ENTL ENTELLUS MEDICAL INC | A Award deriv | 2017-07-14 | 2017-07-18 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ENTL ENTELLUS MEDICAL INC | A Award | 2017-07-14 | 2017-07-18 | 3,750 | — | $0 | 3,750 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2013-08-13 | 2013-08-14 | 1,070 | $81.86 | $87.6K | 17,315 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2013-08-08 | 2013-08-12 | 4,500 | — | $0 | 4,500 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2013-08-08 | 2013-08-12 | 2,250 | — | $0 | 18,385 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2012-08-09 | 2012-08-13 | 4,500 | — | $0 | 4,500 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2012-08-09 | 2012-08-13 | 2,250 | — | $0 | 16,135 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | D To issuer deriv | 2012-01-18 | 2012-01-18 | 16,792 | — | $0 | 0 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | D To issuer deriv | 2012-01-18 | 2012-03-15 | 17,507 | — | $0 | 0 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | D To issuer | 2012-01-18 | 2012-01-18 | 13,885 | — | $0 | 0 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | D To issuer | 2012-01-18 | 2012-03-15 | 13,885 | — | $0 | 0 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | M Exercise deriv | 2012-01-11 | 2012-01-13 | 12,500 | — | $0 | 0 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | M Exercise deriv | 2012-01-11 | 2012-01-13 | 12,500 | — | $0 | 0 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | F Tax w/h | 2012-01-11 | 2012-01-13 | 8,999 | $48.60 | $437.4K | 13,885 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | M Exercise | 2012-01-11 | 2012-01-13 | 12,500 | $34.99 | $437.4K | 22,884 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | M Exercise | 2012-01-11 | 2012-01-13 | 12,500 | $8.23 | $102.9K | 12,500 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | F Tax w/h | 2012-01-11 | 2012-01-13 | 2,116 | $48.60 | $102.8K | 10,384 | SEC↗ |